Pass the Dietary Supplement Innovation Act to modernize FDA drug preclusion rules, create clearer and more transparent standards, protect longstanding dietary supplement ingredients, and preserve consumer access to dietary supplements.

Diana Harshbarger · Tennessee · Republican

policy impact 0.55 specificity 0.86 extraction confidence 84%

Commitment kind: outcome. Promised action: Pass the Dietary Supplement Innovation Act to modernize FDA drug preclusion rules and establish clearer standards for drug preclusion decisions.. Promised outcome: Regulatory certainty for manufacturers, transparency and predictability in the drug preclusion framework, protection for longstanding supplement ingredients, and continued consumer access to dietary supplements.. Deadline: unknown; not assumed expired. Federal office press release by Rep. Diana Harshbarger announcing the Dietary Supplement Innovation Act during her service as U.S. Representative for Tennessee's 1st District.

Contest this claim

Occurrences

My bill delivers the regulatory certainty manufacturers need to innovate and invest with confidence, while establishing transparency and predictability within the drug preclusion framework and preserving consumer access to dietary supplements.

Harshbarger said her Dietary Supplement Innovation Act would provide regulatory certainty, transparency, predictability, and preserve access to dietary supplements.

Harshbarger Introduces Legislation to Fix Outdated FDA Drug Preclusion Rules, Protect Access to Dietary Supplements | Representative Diana Harshbarger
primary · press_release · model gpt-5.5

Action Mrs. Harshbarger introduced the following bill; which was referred to the Committee on Energy and Commerce Bill Number H.R. 10336 Bill Version Introduced in House (IH) Short Title Dietary Supplement Innovation Act Full Title To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.

Harshbarger introduced H.R. 10336, the Dietary Supplement Innovation Act, to amend federal food and drug law to clarify drug preclusion rules and protect consumer access to dietary supplements.

H.R. 10336 (IH) - Dietary Supplement Innovation Act - BILLS-119hr10336ih | Content Details | GovInfo
primary · other · model gpt-5.5

Evidence

verified · Source version 70945 · locator 1263

Mrs. Harshbarger introduced the following bill; which was referred to the Committee on Energy and Commerce

Fetched verbatim passage. AI summary (separate from source): Official GovInfo metadata shows H.R. 10336 was introduced and referred to committee on September 10, 2026, not enacted.

unresolved same_term A for effort

H.R. 10336 (IH) - Dietary Supplement Innovation Act - BILLS-119hr10336ih | Content Details | GovInfo
primary · model gpt-5.5 · confidence 98%

Contest this evidence item

verified · Source version 70957 · locator 1091

This Act may be cited as the ``Dietary Supplement Innovation Act''.

Fetched verbatim passage. AI summary (separate from source): The introduced bill text confirms the bill matching the commitment exists, but this is only introduced-in-House text.

unresolved same_term A for effort

H.R. 10336 Introduced in House Text - GovInfo
secondary · model gpt-5.5 · confidence 98%

Contest this evidence item

verified · Source version 70959 · locator 3895

H.R. 10336. A bill to amend the Federal Food, Drug, and Cosmetic Act

Fetched verbatim passage. AI summary (separate from source): The Congressional Record records Harshbarger’s public bill introduction, a concrete legislative attempt within the lookback window.

unresolved same_term A for effort

CREC-2026-09-10-pt1-PgH5531.pdf
secondary · model gpt-5.5 · confidence 97%

Contest this evidence item

verified · Source version 70961 · locator 3766

today introduced the Dietary Supplement Innovation Act, legislation that modernizes the Food and Drug Administration’s (FDA) drug preclusion provision

Fetched verbatim passage. AI summary (separate from source): An archived official office release describes the effort and intended policy changes, but frames them as introduced legislation, not passed law.

unresolved same_term A for effort

Harshbarger Introduces Legislation to Fix Outdated FDA Drug Preclusion Rules, Protect Access to Dietary Supplements - Rep. Diana Harshbarger Official Press Release | LegiStorm
secondary · model gpt-5.5 · confidence 93%

Contest this evidence item

Assessments

Public state: pending As of 2026-09-28 · verified · . Original AI recommendation (not independently established): unresolved. unknown A for effort

The commitment is to pass or achieve the Dietary Supplement Innovation Act’s regulatory changes, not merely introduce the bill. Verified evidence shows Harshbarger introduced H.R. 10336 and that it was referred to the House Committee on Energy and Commerce, with bill text matching the Dietary Supplement Innovation Act, but no verified passage shows enactment or implementation by the as_of_date. Because there is documented candidate effort but no enacted outcome and no expired deadline, the promise remains unresolved.

provider codex_cli · model gpt-5.5 · confidence 98%